ODENSOMAB 60MG INJECTION

Odensomab 60mg Injection is an active substance Denosumab. It is a medicine for treating osteoporosis, defined by weaker bones. It can also be prescribed to avoid bone problems for patients suffering from certain kinds of cancer, like bone metastases and multiple myeloma. The denosumab 60mg injectable acts by blocking the activity of a protein known as RANK Ligand, which plays a part in degrading bone tissue. Research has shown that it can boost bone density while reducing fracture risk among postmenopausal females with osteoporosis, as well as those suffering from cancer-related loss of bone. Close monitoring of renal function could be required in patients with moderate impairment in their renal function.
Odensomab, 60mg injection, should not be administered to patients who have a history of hypersensitivity or allergic responses to any of its ingredients. A proper vitamin D and calcium supplementation is necessary to guarantee the treatment. It is not recommended for use in young children or adolescents. The safety and effectiveness of the medication in the pediatric population have not been proven. Therefore, it is not recommended for those under 18 years old. This medication should be taken cautiously for patients who have hypoparathyroidism characterized by low levels of parathyroid hormone.